A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine

Neuron

Volumn 16, Issue 3, 1996, Pages 631-639

  Bonci, Antonello ^a   Williams, John T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 (4 HYDROXYPHENYL) 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE DEAMINASE; COCAINE; CYCLIC AMP; DOPAMINE; DOPAMINE RECEPTOR; FORSKOLIN; MORPHINE; PROBENECID;

ADDICTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; INHIBITORY POSTSYNAPTIC POTENTIAL; LIMBIC CORTEX; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR BLOCKING; SYNAPTIC TRANSMISSION;

EID: 0029916083     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80082-3     Document Type: Article

References (50)

1. Ackerman, J.M., and White, F.J. (1992). Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. Eur. J. Pharmacol. 218, 171-173.
2. Barber, R., and Butsher, R.W. (1981). The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells. Mol. Pharmacol. 19, 38-43.
3. Beavo, J.A., and Reifsnyder, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11, 150-155.
4. Cameron, D.L., and Williams, J.T. (1993). Dopamine D1 receptors facilitate transmitter release. Nature 366, 344-347.
5. Cameron, D.L., and Williams, J.T. (1994). Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14, 6763-6767.
6. Cheramy, A., Leviel, V., and Glowinski, J. (1981). Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
7. Cunha, R.A., Sebastial, A.M., and Ribeiro, J.A. (1992). Ecto-5′-nucleotidase is associated with cholinergic nerve terminal in the hippocampus but not the cerebral cortex of the rat. J. Neurochem. 59, 657-666.
8. Dunwiddie, T.V. (1985). The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27, 63-139.
9. Dunwiddie, T.V., and Diao, L. (1994). Extracellular adenosine concentrations in hippocampal slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268, 537-545.
10. Egawa, M., Hoebel, B.G., and Stone, E.A. (1988). Use of microdialysis to measure brain noradrenergic receptor function in vivo. Brain Res. 458, 303-308.
11. Geffen, L.B., Jessell, T.M., Cuello, A.C., and Iversen, L.L. (1976). Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258-260.
12. Gereau, R.W., and Conn, P.J. (1994). Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron 12, 1121-1129.
13. Haas, H.L., and Greene, R.W. (1988). Endogenous adenosine inhibits hippocampal CA1 neurones: further evidence from extra- and intracellular recording. Nauyn-Schmedeberg's Arch. Pharmacol. 337, 561-565.
14. Henry, D.J., and White, F.J. (1991). Repeated cocaine ad ministration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258, 882-890.
15. Henry, D.J., and White, F.J. (1995). The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15, 6287-6299.
16. Henry, D.J., Greene, M.A., and White, F.J. (1989). Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmacol. Exp. Ther. 251, 833-839.
17. Johnson, S.W., and North, R.A. (1992). Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. 450, 455-468.
18. Kalivas, P.W., and Duffy, P. (1993a). Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13, 266-275.
19. Kalivas, P.W., and Duffy, P. (1993b). Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13, 276-284.
20. Kalivas, P.W., and Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16, 223-244.
21. Korf, J., Zieleman, M., and Westerink, B.H.C. (1976). Dopamine release in substantia nigra? Nature 260, 257-258.
22. Krupinski, J., Coussen, F., Bakalyar, H.A., Tan, W.-J., Feinstein, P.G., Ort, K., Slaughter, C., Reed, R.R., and Gilman, A.G. (1989). Adenylyl cyclase amino acid sequence: possible channel-or transporter-like structure. Science 244, 1558-1564.
23. Lazarena, S., Marriott, D.B., and Nahorski, S.R. (1985). Differential effects of selective and non-selective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices. Brain Res. 361, 91-98.
24. Linden, J. (1989). Adenosine deaminase for removing adenosine: how much is enough? Trends Pharmacol. Sci. 10, 260-263.
25. Manzoni, O.J., Manabe, T., and Nicoll, R.A. (1994). Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265, 2098-2101.
26. Mayfield, R.D., Larson, G., and Zahniser, N.R. (1992). Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573, 331-335.
27. Mercuri, N.B., Calabresi, P., and Bernardi, G. (1989). The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. Brit. J. Pharmacol. 98, 127-134.
28. Mitchell, J.B., Lupica, C.A., and Dunwiddie, T.V. (1993). Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13, 3439-3447.
29. Nestler, E.J. (1992). Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
30. Nestler, E.J. (1993). Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11, 995-1006.
31. Nestler, E.J. (1994). Hard target: understanding dopaminergic neuro-transmission. Cell 79, 923-926.
32. Paden, C., Wilson, C.J., and Groves, P.M. (1976). Amphetamine-induced release of dopamine from the substantia nigra in vitro. Life Sci. 19, 1499-1506.
33. Peris, J., Boyson, S.J., Cass, W.A., Curella, P., Dwaskin, L.P., Larson, G., Lin, L.-H., Yasuda, R.P., and Zahniser, N.R. (1990). Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253, 38-44.
34. Ragazzi, E., Wu, S.-N., Shryock, J., and Belardinelli, L. (1991). Electrophysiological and receptor binding studies to assess activation of the cardiac adenosine receptor by adenine nucleotides. Circ. Res. 68, 1036-1044.
35. Robertson, G.S., Damsma, G., and Fibiger, H.C. (1991). Characterization of dopmaine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11, 2209-2216.
36. Robinson, T.E., and Becker, J.B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animals models of amphetamine psychosis. Brain Res. Rev. 11, 157-198.
37. Robinson, T.E., and Berridge, K.C. (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247-291.
38. Roseboom, P.H., Hewlett, G.H.K., and Gnegy, M.E. (1990). Repeated amphetamine administration alters the interaction between D1-stimulatied adenylyl cyclase activity and calmodulin in rat striatum. J. Pharmacol. Exp. Ther. 255, 197-203.
39. Rosenberg, P.A., and Dichter, M.A. (1989). Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J. Neurosci. 9, 2654-2663.
40. Rosenberg, P.A., Knowles, R., Knowles, K.P., and Li, Y.J. (1994). β-Adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci. 14, 2953-2965.
41. Schoen, S.W., and Kreutzberg, G.W. (1995). Evidence that 5′-nucleotidase is associated with malleable synapses: an enzyme cytochemical investigation of the olfactory bulb of adult rats. Neuroscience 65, 37-50.
42. 6-phenylisopyladenosine. Naunyl-Schmiedeberg's Arch. Pharmacol. 313, 179-187.
43. Stoof, J.C., and Kebabian, J.W. (1981). Opposing roles for D1- and D2-dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368.
44. Terwilliger, R.Z., Beitner-Johnson, D., Sevarino, K.A., Crain, S.M., and Nestler, E.J. (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110.
45. Timmerman, W., and Abercrombie, E.D. (1995). Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse, in press.
46. Wise, R.A., and Rompre, P.P. (1989). Brain DA and reward. Annu. Rev. Psychol. 40, 191-225.
47. Woolverton, W.L., and Johnson, K.M. (1992). Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13, 193-200.
48. Wu, Y., Mercuri, N.B., and Johnson, S.W. (1995). Presynaptic inhibition of γ-aminobutyric acid B-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 273, 576-581.
49. Xu, M., Hu, X.-T., Cooper, D.C., Moratalla, R., Grabiel, A.M., White, F.J., and Tonegawa, S. (1994). Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79, 945-955.
50. Zimmermann, H., Vogel, M., and Laube, U. (1993). Hippocampal localization of 5′-nucleotidase as revealed by immunocytochemistry. Neuroscience 55, 105-112.